Frontlight ResearchEarly access
Trial site
Dell Children's Blood and Cancer Center
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers9 trials
- Neuroblastoma7 trials
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Meningioma1 trial
- Sarcoma1 trial
- Phase
- Phase 26 trials
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Giselle Sholler9 trials
Running trials
Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Recruiting
Active, not recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Active, not recruiting
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers5 recruiting
- Neuroblastoma3 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026